Higher percentage of CD133 cells is associated with poor prognosis in colon carcinoma patients with stage IIIBReport as inadecuate




Higher percentage of CD133 cells is associated with poor prognosis in colon carcinoma patients with stage IIIB - Download this document for free, or read online. Document in PDF available to download.

Journal of Translational Medicine

, 7:56

First Online: 07 July 2009Received: 29 November 2008Accepted: 07 July 2009DOI: 10.1186-1479-5876-7-56

Cite this article as: Li, CY., Li, BX., Liang, Y. et al. J Transl Med 2009 7: 56. doi:10.1186-1479-5876-7-56

Abstract

BackgroundCancer stem cell model suggested that tumor progression is driven by the overpopulation of cancer stem cells and eradicating or inhibiting the symmetric division of cancer stem cells would become the most important therapeutic strategy. However, clinical evidence for this hypothesis is still scarce. To evaluate the overpopulation hypothesis of cancer stem cells the association of percentage of CD133 tumor cells with clinicopathological parameters in colon cancer was investigated since CD133 is a putative cancer stem cell marker shared by multiple solid tumors.

Patients and methodsTumor tissues matched with adjacent normal tissues were collected from 104 stage IIIB colon cancer patients who were subject to radical resection between January, 1999 to July, 2003 in this center. The CD133 expression was examined with immunohistochemical staining. The correlation of the percentage of CD133 cell with clinicopathological parameters and patients- 5-year survival was analyzed.

ResultsThe CD133 cells were infrequent and heterogeneous distribution in the cancer tissue. Staining of CD133 was localized not only on the glandular-luminal surface of cancer cells but also on the invasive budding and the poorly differentiated tumors with ductal structures. Both univariate and multivariate survival analysis revealed that the percentage of CD133 cancer cells and the invasive depth of tumor were independently prognostic. The patients with a lower percentage of CD133 cancer cells less than 5% were strongly associated with a higher 5-year survival rate than those with a higher percentage of CD133 cancer cells greater than or equal to 55%. Additionally, no correlation was obtained between the percentage of CD133 cancer cells and the other clinicopathological parameters including gender, age, site of primary mass, pathologic types, grades, and invasive depth.

ConclusionThe fact that a higher percentage CD133 cells were strongly associated with a poorer prognosis in patients with locally advanced colon cancer implicated that CD133 cancer cells contribute to the tumor progression, and the overpopulation hypothesis of cancer stem cell seems reasonable.

Electronic supplementary materialThe online version of this article doi:10.1186-1479-5876-7-56 contains supplementary material, which is available to authorized users.

Download fulltext PDF



Author: Chun-Yan Li - Bao-Xiu Li - Yi Liang - Rui-Qing Peng - Ya Ding - Da-Zhi Xu - Xin Zhang - Zhi-Zhong Pan - De-Sen Wan - Yi-X

Source: https://link.springer.com/







Related documents